---
tags:
  - iints/source
  - iints/source/pharmacology
source_id: "heise_2017_fiasp_pkpd"
source_bucket: "packaged_evidence"
category: "pharmacology"
component: "insulin_action_profiles"
url: "https://doi.org/10.1007/s40262-017-0510-8"
doi: "10.1007/s40262-017-0510-8"
status: active
---

# A Faster-Onset Formulation of Insulin Aspart

> [!info] What this source supports
> Reference for rapid insulin onset assumptions in therapy profiles.

| Field | Value |
| --- | --- |
| Source ID | `heise_2017_fiasp_pkpd` |
| Bucket | `packaged_evidence` |
| Category | `pharmacology` |
| SDK component | `insulin_action_profiles` |
| DOI | 10.1007/s40262-017-0510-8 |
| URL | https://doi.org/10.1007/s40262-017-0510-8 |
| Origin file | `src/iints/presets/evidence_sources.yaml` |

## Citation

Heise T, et al. Clin Pharmacokinet. 2017;56(5):551-559.

## User Interpretation

Use this source to explain **why the SDK default, metric, dataset, or hardware-safety boundary exists**. It is evidence support for pre-clinical simulation and documentation, not a medical approval claim.
